key: cord-0022616-7w7bi56o
authors: Kaya, Abdurrahman; Yıldız Kaya, Sibel
title: Definition of HCV Reactivation [Letter]
date: 2021-10-22
journal: Int Med Case Rep J
DOI: 10.2147/imcrj.s342905
sha: 21e8f9dd0cfdccde3e8a49e711af9bc28cef958b
doc_id: 22616
cord_uid: 7w7bi56o

nan

We have read with great interest the paper by Lensen et al. 1 They reported a case of HCV reactivation developing following a COVİD 19 vaccination. However, we have some concerns regarding the case.

Firstly, the patient had decompensated cirrhosis in 2015. However, its etiology was not clearly mentioned. It should have been specified in the text.

Secondly, she was diagnosed with hepatitis C virus infection in 2007. The tests including HCV-RNA and genotype were not available and it was not known whether she achieved a sustained viral response. Also, she had slightly increased liver enzymes since 2011. We think it is probably to be caused by HCV.

Thirdly, more importantly, the term "reactivation of HCV infection" is used for patients resolved from the infection, namely a positive HCV antibody test and a negative for HCV RNA. 3 However, it is not known in this case. Also, reactivation of HCV infection is defined as a rise in the HCV RNA level of at least 1 log 10 IU/mL from baseline, as HCV RNA levels in chronically infected patients may fluctuate by about 0.5 log 10 IU/mL. 2, 3 It is crystal clear that the patient does not meet the criteria for a case definition because follow-up HCV RNA levels were not present. In the patient, it could be only stated that she had hepatitis with the elevation of liver enzymes. Due to findings including fever, elevated CRP and somnolence, and abdominal pain, the systemic infection including sepsis, cholangitis and spontaneous bacterial peritonitis are primarily considered in this case. In the light of these data, it is impossible to state that the patient had reactivation of HCV infection developing following a COVID-19 vaccination.

The authors report no conflicts of interest for this communication. 

The International Medical Case Reports Journal is an international, peer-reviewed open-access journal publishing original case reports from all medical specialties. Previously unpublished medical posters are also accepted relating to any area of clinical or preclinical science. Submissions should not normally exceed 2,000 words or 4 published pages including figures, diagrams and references. The manuscript management system is completely online and includes a very quick and fair peer-review system, which is all easy to use. Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors. 

Hepatitis C virus reactivation following COVID-19 vaccination-A case report

Hepatitis C virus reactivation in patients receiving cancer treatment: a prospective observational study

Acute exacerbation and reactivation of chronic hepatitis C virus infection in cancer patients